A new standard in wheat immune reactivity testing that adds seven new wheat markers to assess immune responses to ...

Scientists have taken a significant step toward neutralizing Epstein-Barr virus. Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV ...

SIRPα immunotherapy include targeting overexpressed CD47 in cancers to boost macrophage activity, using dual function molecules to enhance efficacy, and innovative drug designs reducing red blood cell ...

Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM ESTCompany ParticipantsRafael Amado - President and Head ...

Thousands of lawsuits in the U.S. allege that the agrochemical maker Bayer failed to warn people that its popular weedkiller ...

Measles can be severe for those who aren't immune. Here's how to spot the early signs of the infection ...

Emerging opportunities in the Ebola Virus sector include development of novel vaccines and therapeutics, such as low-cost vaccines and host-directed treatments. Innovative companies focus on pipeline ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...

This study reports an important and novel finding that TENT5A, an enzyme involved in fine-tuning poly(A) tail length on selected mRNAs, is required for proper enamel mineralization in mice. The ...

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...

The webinar highlights advances in high-throughput gene and protein synthesis platforms that accelerate antibody discovery and optimization. Using accurate HTP Strings DNA fragments improves cloning ...

Q4 2025 Earnings Call February 17, 2026 8:30 AM ESTCompany ParticipantsKendra Sweeney - Vice President of Investor Relations ...